The cancer therapeutics market size is expected to reach US$ 5,31,538.02 million by 2031 from US$ 2,30,423.56 million in 2024. The market is estimated to record a CAGR of 12.8% from 2025 to 2031.

Executive Summary and Global Market Analysis

The global cancer therapeutics market is witnessing considerable expansion, fueled by the escalating global burden of breast and lung cancer and burgeoning investments in oncology research. Cancer therapeutics includes a broad spectrum of treatments aimed at controlling or curing cancer. Key treatment metrics often utilized are chemotherapy, radiation, immunotherapy, targeted therapy, hormone therapy, surgical procedures, and stem cell therapy. These strategies collectively strive to eliminate or manage cancer cells, alleviate symptoms, and improve patient survival rates. Depending on the cancer type, stage, and the patient's general health, a combination of these therapies is frequently employed to optimize treatment effectiveness.

Download our Sample PDF Report

@ https://www.businessmarketinsights.com/sample/BMIRE00031299

Cancer Therapeutics Market Segmentation Analysis

The cancer therapeutics market analysis is derived from key segmentations: therapy type, indication, and distribution channel.

By therapy type, the market is categorized into chemotherapy, targeted therapy, radiation therapy, hormone therapy, and other therapeutic modalities. Chemotherapy held the dominant position in the market in 2024.

For indications, the market is segmented by blood cancer, lung cancer, breast cancer, colorectal cancer, prostate cancer, stomach cancer, cervical cancer, liver and intrahepatic bile duct cancer, thyroid cancer, and other relevant indications. Lung cancer secured the largest share of the market in 2024.

Regarding distribution channel, the market is divided into hospital pharmacies, retail pharmacies, and online stores. Hospital pharmacies accounted for the largest share of the market in 2024.

Cancer Therapeutics Market Drivers and Opportunities

As per the World Health Organization's media center, various types of cancer contribute to approximately 1 in every 6 deaths globally. In 2022, there were an estimated 20 million new cancer cases and 9.7 million associated deaths; the burden is projected to increase by around 77% by 2050, placing further strain on health systems and communities. The American Cancer Society indicates that 5–10% of all cancers originate from inherited genes. Numerous genes linked to an individual's predisposition to cancer have been identified. For instance, mutations in inherited cancer predisposition genes like BRCA1 and BRCA2 elevate the risk of developing breast, ovarian, and prostate cancers. Breast cancer is considered the most prevalent cancer among women, with its incidence continuously rising worldwide due to environmental impact, genetic susceptibility, hormone imbalances, and lifestyle changes. Moreover, breast cancer is among the most prevalent cancers in the U.S.

About Us:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications